Drugs / chondrocyte-alginate gel suspension
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00004487 | May 1999 → ? | vesicoureteral reflux | FDA Office of Orphan Products Development | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | chondrocyte-alginate gel suspension | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004487 ↗ |
| Route | Other | “Chondrocyte alginate gel suspension is injected into the submucosa of the bladder at the vesicoureteral junction” NCT00004487 ↗ |